Spotlight
Clinical
CME
Partners
Alcon updates NDA; FDA approves wider treatment range
Alcon, over a 2-day span in late June, filed one new drug application (NDA) with the FDA and received approval for another.
Related Videos
View All
Related Content
Alcon, over a 2-day span in late June, filed one new drug application (NDA) with the FDA and received approval for another.
